Table 4.

Immunophenotyping of inflammatory cells.

VariablePolymyalgia Rheumatica without GCA, n = 13Arteriosclerosis, GCA, n = 20GCA, n = 27PPVp
CD20 absent13 (100)17 (85.0)8 (29.6)0.863**
  ≤ 50 (0)0 (0)5 (18.5)
  > 50 (0)3 (15.0)14 (51.9)
CD3 absent6 (46.2)10 (50.0)1 (3.7)0.605***
  ≤ 56 (46.2)5 (25.0)0 (0)
  > 51 (7.4)5 (25.0)26 (96.3)
CD4 absent9 (69.2)15 (75.0)1 (3.7)0.743***
  ≤ 52 (15.4)2 (10.0)1 (3.7)
  > 52 (15.4)3 (15.0)25 (93.6)
CD8 absent13 (100)16 (80.0)4 (14.8)0.852***
  ≤ 50 (0)1 (5.0)0 (0)
  > 50 (0)3 (15.0)23 (85.2)
CD68 absent13 (100)16 (80.0)4 (14.8)0.852***
  ≤ 50 (0)1 (5.0)0 (0)
  > 50 (0)3 (15.0)23 (85.2)
Mast cells absent10 (76.9)14 (70.0)12 (44.4)0.862***
  ≤ 52 (15.4)6 (30.0)11 (40.8)
  > 51 (7.7)0 (0)4 (14.8)
CD138 absent13 (100)17 (85.0)8 (29.6)0.862***
  ≤ 50 (0)0 (0)4 (14.8)
  >50 (0)3 (15.0)15 (55.6)
Antigen-presenting cells (S100)1 (737)5 (25.5)25 (92.6)0.806***
Antigen-presenting cells (CDla)0 (0)3 (15.0)7 (25.9)NS
  • NS: not significant;

  • ** significant,

  • *** highly significant; PPV: positive predictive value.